| Brittany N Hemmele, APN | |
|
8600 N State Route 91, Peoria, IL 61615-9541 | |
| (309) 683-5050 | |
| (309) 683-5335 |
| Full Name | Brittany N Hemmele |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 8600 N State Route 91, Peoria, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013369149 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 209-014466 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Medical Center | Peoria, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Researchers in Finland have conducted a study showing that the neutralizing bodies generated following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – generally persist for at least a year.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Noting that President Barack Obama's "only presence at the XIX International AIDS Conference (AIDS 2012) is a 50-second cameo in a three-minute video welcoming delegates," Bloomberg reports that his "absence ... has activists talking."
Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the ESTRO 38 conference.
› Verified 2 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Researchers in Finland have conducted a study showing that the neutralizing bodies generated following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – generally persist for at least a year.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Noting that President Barack Obama's "only presence at the XIX International AIDS Conference (AIDS 2012) is a 50-second cameo in a three-minute video welcoming delegates," Bloomberg reports that his "absence ... has activists talking."
Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the ESTRO 38 conference.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany N Hemmele, APN 8600 N State Route 91, Peoria, IL 61615-9541 Ph: (309) 683-5050 | Brittany N Hemmele, APN 8600 N State Route 91, Peoria, IL 61615-9541 Ph: (309) 683-5050 |
News Archive
Researchers in Finland have conducted a study showing that the neutralizing bodies generated following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – generally persist for at least a year.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Noting that President Barack Obama's "only presence at the XIX International AIDS Conference (AIDS 2012) is a 50-second cameo in a three-minute video welcoming delegates," Bloomberg reports that his "absence ... has activists talking."
Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the ESTRO 38 conference.
› Verified 2 days ago
Mr. Ryan Eugene Parnham, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 530 Ne Glen Oak Ave, Suite 108, Peoria, IL 61537 Phone: 309-624-8818 | |
Faye Yetton, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2015 W Austin Dr, Peoria, IL 61614 Phone: 309-256-0632 | |
Linda Schmidgall, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 420 Ne Glen Oak Ave, Suite 200, Peoria, IL 61603 Phone: 309-624-5100 Fax: 309-624-5569 | |
Sandra L. Peach, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 420 Ne Glen Oak Ave, Peoria, IL 61603 Phone: 309-655-2343 Fax: 309-655-3948 | |
Roxanne Mclaughlin, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8940 N Wood Sage Rd, Peoria, IL 61615 Phone: 309-243-3000 Fax: 309-243-3274 | |
Suzanne D Tietjen, BSN, NNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-2974 |